1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Intestinal Polyposis: new trials by email Literature Review of Intestinal Polyposis trials Research Report on Intestinal Polyposis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP) Celecoxib, Placebo - Adenomatous Polyposis Coli | Phase 3 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 106 | 2006-09-01 | 2021-02-21 |
Adenomatous Polyposis Coli (1)
Adenoma (1) · Adenomatous Polyps (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genetic Diseases, Inborn (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Celecoxib (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)
Belgium (1) · Czechia (1) · Hong Kong (1) · Hungary (1) · Israel (1) · Italy (1) · Puerto Rico (1) · Slovakia (1) · South Africa (1) · Spain (1) · Sweden (1) · Ukraine (1) · United Kingdom (1) · United States (1)